← back to search

Douglas E. Peterson

UConn Health · US
Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research interests include Oral health in cancer treatment, Head and Neck Cancer Studies, Cancer Diagnosis and Treatment, and Oral Health Pathology and Treatment.
h-index
53
citations
14,549
works
203
NIH funding
primary concept
Mucositis
email

Recent publications

International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study
International Journal of Radiation Oncology*Biology*Physics 2025cited by 19position: middledoi
Oral Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors: Call to Action.
2025cited by 1position: contributordoi
The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw: Summary and implications for dental team members.
2025cited by 1position: contributordoi
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline.
2024cited by 79position: contributordoi
International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study
2024cited by 9position: contributordoi
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights.
2024cited by 6position: contributordoi
Gaps in Access to Medically Necessary Dental Care for Patients Living With and Beyond Cancer: We Must Do Better.
2024cited by 3position: contributordoi
Use of Biosimilar Medications in Oncology.
2022cited by 21position: contributordoi
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial.
2022cited by 12position: contributordoi
Embracing multi-causation of periodontitis: Why aren't we there yet?
2022cited by 7position: contributordoi
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer
Journal of Clinical Oncology 2021cited by 93position: middledoi
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
2021cited by 86position: contributordoi
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
2021cited by 70position: contributordoi
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial
Bone Marrow Transplantation 2021cited by 19position: middledoi
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
Journal of Clinical Oncology 2019cited by 406position: middledoi
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines
Supportive Care in Cancer 2019cited by 89position: middledoi
World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies.
2019cited by 51position: contributordoi
World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders.
2019cited by 16position: contributordoi
World Workshop on Oral Medicine VII: Targeting the microbiome for oral medicine specialists-Part 1. A methodological guide.
2019cited by 15position: contributordoi
World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome-A systematic review.
2019cited by 10position: contributordoi
World Workshop on Oral Medicine VII: Editorial.
2019cited by 3position: contributordoi
Response to "prognostic biomarkers in oral leukoplakia".
2019cited by 0position: contributordoi
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 2018cited by 97position: middledoi
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice
Cancer Medicine 2016cited by 69position: firstdoi
Oral medicine (stomatology) across the globe: birth, growth, and future
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 2015cited by 60position: middledoi
World Workshop on Oral Medicine VI: Controversies regarding dental management of medically complex patients: assessment of current recommendations
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 2015cited by 33position: middledoi
Using high throughput sequencing to explore the biodiversity in oral bacterial communities
Molecular Oral Microbiology 2012cited by 120position: middledoi

Grants

Connection to Southeastern Universities Research AssociationNetwork
NSF9120751$21,6191992–1993PIRePORTER

Frequent collaborators

· 16 papers (2019–2025)Alessandro Villa · UCSF Helen Diller Family Comprehensive Cancer Center6 papers (2019–2025)Arjan Vissink · Hanze University of Applied Sciences4 papers (2019–2021)Alexander R. Kerr · McGill University4 papers (2019–2022) · 4 papers (2019–2021)Nofisat Ismaila · McMaster University3 papers (2024–2025)Barbara A. Murphy · Vanderbilt University3 papers (2019–2024)Ellen Frandsen Lau · Microbiology Society3 papers (2019–2022)David H. Yang · BC Cancer3 papers (2024–2025)Camile S. Farah · The University of Western Australia3 papers (2019–2019)Erin Watson · McGill University3 papers (2024–2025)Yvonne M. Mowery · Duke University3 papers (2024–2025) · 3 papers (2024–2025) · 3 papers (2019–2019)K. Delli · University Medical Center Groningen3 papers (2019–2019)Paolo Bossi · University of Hong Kong3 papers (2019–2025)Randall J. Kimple · University of Wisconsin–Madison2 papers (2021–2021)David Ojeda · New York University2 papers (2019–2019)Ingrid Glurich · Marshfield Clinic Research Institute2 papers (2019–2019)Ivan Alajbeg · Springer Nature2 papers (2024–2025)